Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

UFL1 antibody (AA 175-225)

This anti-UFL1 antibody is a Rabbit Polyclonal antibody detecting UFL1 in IP. Suitable for Human.
Catalog No. ABIN7451535

Quick Overview for UFL1 antibody (AA 175-225) (ABIN7451535)

Target

See all UFL1 Antibodies
UFL1 (UFM1-Specific Ligase 1 (UFL1))

Reactivity

  • 17
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
Human

Host

  • 17
Rabbit

Clonality

  • 17
Polyclonal

Conjugate

  • 12
  • 1
  • 1
  • 1
  • 1
  • 1
This UFL1 antibody is un-conjugated

Application

  • 16
  • 8
  • 3
  • 1
  • 1
  • 1
Immunoprecipitation (IP)
  • Binding Specificity

    • 7
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 175-225

    Purpose

    Rabbit anti-UFL1 Antibody, Affinity Purified

    Predicted Reactivity

    Mouse,Rat

    Purification

    Affinity Purified

    Immunogen

    between AA 175 and 225

    Isotype

    IgG
  • Application Notes

    IP: 2 - 10 μg/mg lysate

    WB: Not recommended

    Restrictions

    For Research Use only
  • Concentration

    1000 μg/mL

    Buffer

    Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Expiry Date

    12 months
  • Target

    UFL1 (UFM1-Specific Ligase 1 (UFL1))

    Alternative Name

    UFL1

    Background

    Background: UFM1-specific ligase 1 (UFL1) is and E3 UFM1-protein ligase that mediates ufmylation of target proteins such as DDRGK1/C20orf116. The function of ufmylation is unknown. UFL1 may act as a tumor suppressor by inhibiting cell invasion, blocking NF-kappa-B signaling and increasing stability of CDK5RAP3 [taken from the Universal Protein Resource (UniProt) O94874].

    Gene ID

    23376

    NCBI Accession

    NP_056138

    UniProt

    O94874
You are here:
Chat with us!